Overview


According to FutureWise analysis the market for Arteriovenous Fistula Treatment in 2023 is US$ 0.78 billion, and is expected to reach US$ 1.25 billion by 2031 at a CAGR of 6.10%.

Arteriovenous Fistula Treatment involves the creation or management of an arteriovenous fistula (AVF), a surgically constructed connection between an artery and a vein. This medical intervention is primarily employed to provide a durable and reliable access point for hemodialysis, a life-saving treatment for individuals with end-stage renal disease (ESRD). Creating an AVF involves a surgical procedure in which an artery and a nearby vein are joined together. These fusion redirects high-pressure arterial blood flow into the low-pressure venous system, leading to the dilation and strengthening of the vein over time. Once matured, the AVF becomes a preferred site for hemodialysis needle placement, allowing for efficient and sustained removal and return of blood during dialysis sessions.

AVF treatment is integral to the long-term management of ESRD patients who require regular hemodialysis. Compared to other types of vascular access (such as arteriovenous grafts or central venous catheters), AVFs offer several advantages. They are associated with lower rates of infection and thrombosis, longer functional lifespan, and reduced healthcare costs over the long term. Additionally, AVFs facilitate higher blood flow rates during dialysis, leading to more effective clearance of waste products and toxins. 

FutureWise Market Research has published a report that provides an insightful analysis of Arteriovenous Fistula Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Arteriovenous Fistula Treatment Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Becton Dickinson, and Company
  • Medtronic
  • B. Braun Melsungen Ag
  • Cook Medical
  • Teleflex Incorporated
  • Fresenius Medical Care AGCo. KGaA
  • NxStage Medical, Inc.
  • Poly Medicure Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

The surge in the prevalence of chronic kidney diseases and end-stage renal disease (ESRD) necessitates the creation of arteriovenous fistulas for hemodialysis access. This drives the demand for arteriovenous fistula treatments. The global aging population is more susceptible to renal disorders, leading to an increased need for arteriovenous fistula creation. This demographic trend significantly contributes to the demand for arteriovenous fistula treatment. Ongoing advancements in vascular surgery techniques and technologies have led to safer and more effective arteriovenous fistula creation procedures, boosting market growth. Government initiatives to improve access to healthcare, especially for renal patients, can positively impact the arteriovenous fistula treatment market. Policies supporting early intervention and better management of renal diseases can drive demand.

However, a lack of awareness among healthcare professionals and patients about the importance of arteriovenous fistulas for hemodialysis access can hinder market growth. Education and awareness campaigns are crucial to address this issue. Not all arteriovenous fistulas successfully mature into usable access points for hemodialysis. Factors such as vessel quality and patient anatomy can impact the success rate, posing a challenge for effective treatment.

By Type

  • Arteriovenous fistulas
  • Dural arteriovenous fistulas
  • Peripheral arteriovenous fistulas
  • Pial or cerebral arteriovenous fistulas
  • Others

By Treatment Type

  • Drugs
  • Transcatheter Embolization
  • Ultrasound-guided Compression
  • Surgery

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the prevalence of kidney disease rapidly increasing, posing a concerning trend, robust healthcare infrastructure, the prominent presence of key industry players, and heightened research endeavors in this geographical region. Conversely, the Asia-Pacific region is poised for substantial expansion in the forecast period due to the increasing prevalence of ESRD (end-stage renal disease) and the rising number of individuals requiring haemodialysis treatment.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on Arteriovenous Fistula Treatment Market By Type, By Treatment Type and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections, which are represented in the format of data sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors, which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Arteriovenous Fistula Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Arteriovenous Fistula Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Arteriovenous Fistula Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Arteriovenous Fistula Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Arteriovenous fistulas
        2. Dural arteriovenous fistulas
        3. Peripheral arteriovenous fistulas
        4. Pial or cerebral arteriovenous fistulas
        5. Others

  • 8.   Global Arteriovenous Fistula Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drugs
        2. Transcatheter Embolization
        3. Ultrasound-guided Compression
        4. Surgery

  • 9.   North America Arteriovenous Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Arteriovenous Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Arteriovenous Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Arteriovenous Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Arteriovenous Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Becton Dickinson, and Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. B. Braun Melsungen Ag
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cook Medical.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Teleflex Incorporated
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Fresenius Medical Care AGCo. KGaA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. NxStage Medical, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Poly Medicure Limited
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Arteriosclerosis Detector Market

Read More
Partner

Our Clients